Halama Niels, Spille Anna, Lerchl Tina, Brand Karsten, Herpel Esther, Welte Stefan, Keim Sophia, Lahrmann Bernd, Klupp Fee, Kahlert Christoph, Weitz Jürgen, Grabe Niels, Jaeger Dirk, Zoernig Inka
National Center for Tumor Diseases; Medical Oncology and Internal Medicine VI; University Hospital Heidelberg; Heidelberg, Germany ; Tissue Imaging and Analysis Center (TIGA); BIOQUANT; Heidelberg, Germany.
Oncoimmunology. 2013 Apr 1;2(4):e24116. doi: 10.4161/onci.24116.
The immune system plays an important role in shaping the clinical course of colorectal cancer (CRC). However, it is still unclear how the immune infiltrates of primary CRC lesions and distant metastases by immune effector cells are related to each other. To address this issue, we quantified CD3, CD8 and granzyme B lymphocytes in primary CRC samples and corresponding liver metastases. This analysis showed that the prognostic predictions that can be drawn from the infiltration of immune cells in primary CRCs and their metastases are heterogeneous. To investigate whether such heterogeneity would also be observed within CRC hepatic metastases, the density of the immune infiltrate and cytokine production were assessed in opposite sides of the same metastatic lesion. In addition, tumor-infiltrating lymphocytes were assessed in sequential sections of the same metastatic lesion, with a spacing of 30 μm. In summary, consistent cell counts and cytokine levels were detected within the same lesion. The study of a case of synchronous metastases, however, suggested that different metastatic lesions within the same patient may be heterogeneous, perhaps indicating a major impact for local causes on tumor infiltration by immune cells. In summary, our study demonstrates a consistent degree of heterogeneity between primary tumors and hepatic metastases but an excellent intra-lesional homogeneity. These findings may be of key importance for patient stratification and the development of personalized strategies against CRC.
免疫系统在结直肠癌(CRC)临床病程的形成中发挥着重要作用。然而,原发性CRC病灶和远处转移灶中免疫效应细胞的免疫浸润之间如何相互关联仍不清楚。为解决这一问题,我们对原发性CRC样本及相应肝转移灶中的CD3、CD8和颗粒酶B淋巴细胞进行了定量分析。该分析表明,从原发性CRC及其转移灶中免疫细胞浸润得出的预后预测是异质性的。为研究在CRC肝转移灶内是否也会观察到这种异质性,我们对同一转移灶的相对两侧的免疫浸润密度和细胞因子产生情况进行了评估。此外,在同一转移灶间隔30μm的连续切片中评估肿瘤浸润淋巴细胞。总之,在同一病灶内检测到了一致的细胞计数和细胞因子水平。然而,对一例同步转移病例的研究表明,同一患者体内不同的转移灶可能是异质性的,这或许表明局部因素对免疫细胞肿瘤浸润有重大影响。总之,我们的研究表明原发性肿瘤与肝转移灶之间存在一定程度的异质性,但病灶内具有良好的同质性。这些发现对于患者分层以及制定针对CRC的个性化策略可能至关重要。